Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 5MB, 226 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 22 results:
Author Title [ Type(Desc)] Year
Filters: Author is Platt, R. W.  [Clear All Filters]
Journal Article
S. M. Grandi, Filion, K. B., Hutcheon, J. A., Rosella, L. C., and Platt, R. W., “Accounting for Repeat Pregnancies in Risk Prediction Models”, Epidemiology, 2021.
G. Simoneau, Moodie, E. E. M., Azoulay, L., and Platt, R. W., “Adaptive Treatment Strategies with Survival Outcomes: An Application to the Treatment of Type 2 Diabetes using a Large Observational Database”, Am J Epidemiol, 2020.
L. L. Lipscombe, Austin, P. C., Alessi-Severini, S., Blackburn, D. F., Blais, L., Bresee, L., Filion, K. B., Kawasumi, Y., Kurdyak, P., Platt, R. W., Tamim, H., and Paterson, J. M., “Atypical antipsychotics and hyperglycemic emergencies: multicentre, retrospective cohort study of administrative data”, Schizophr Res, vol. 154, pp. 54-60, 2014.
A. Mehrabadi, Reynier, P., Platt, R. W., and Filion, K. B., “Domperidone for insufficient lactation in England 2002-2015: A drug utilization study with interrupted time series analysis”, Pharmacoepidemiol Drug Saf, vol. 27, pp. 1316-1324, 2018.
M. Eberg, Platt, R. W., and Filion, K. B., “The Estimation of Gestational Age at Birth in Database Studies”, Epidemiology, vol. 28, pp. 854-862, 2017.
M. Eberg, Platt, R. W., Reynier, P., and Filion, K. B., “Estimation of high-dimensional propensity scores with multiple exposure levels”, Pharmacoepidemiol Drug Saf, 2019.
M. H. Secrest, Platt, R. W., Dormuth, C. R., Chateau, D., Targownik, L., Nie, R., Doyle, C. M., Dell'Aniello, S., and Filion, K. B., “Extreme restriction design as a method for reducing confounding by indication in pharmacoepidemiologic research”, Pharmacoepidemiol Drug Saf, 2019.
B. M. Hicks, Yin, H., Yu, O. H., Pollak, M. N., Platt, R. W., and Azoulay, L., “Glucagon-like peptide-1 analogues and risk of breast cancer in women with type 2 diabetes: population based cohort study using the UK Clinical Practice Research Datalink”, Bmj, vol. 355, p. i5340, 2016.
S. M. Grandi, Vallee-Pouliot, K., Reynier, P., Eberg, M., Platt, R. W., Arel, R., Basso, O., and Filion, K. B., “Hypertensive Disorders in Pregnancy and the Risk of Subsequent Cardiovascular Disease”, Paediatr Perinat Epidemiol, vol. 31, pp. 412-421, 2017.
D. Abrahami, Douros, A., Yin, H., Yu, O. H., Faillie, J. L., Montastruc, F., Platt, R. W., Bouganim, N., and Azoulay, L., “Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study”, Bmj, vol. 363, p. k4880, 2018.
J. Rouette, Yin, H., Yu, O. H. Y., Bouganim, N., Platt, R. W., and Azoulay, L., “Incretin-based drugs and risk of lung cancer among individuals with type 2 diabetes”, Diabet Med, 2020.
K. B. Filion, Azoulay, L., Platt, R. W., Dahl, M., Dormuth, C. R., Clemens, K. K., Hu, N., Paterson, J. M., Targownik, L., Turin, T. C., Udell, J. A., and Ernst, P., “A Multicenter Observational Study of Incretin-based Drugs and Heart Failure”, N Engl J Med, vol. 374, pp. 1145-54, 2016.
M. H. Secrest, Platt, R. W., Reynier, P., Dormuth, C. R., Benedetti, A., and Filion, K. B., “Multiple imputation for systematically missing confounders within a distributed data drug safety network: A simulation study and real-world example”, Pharmacoepidemiol Drug Saf, 2019.
Y. Lian, Yin, H., Pollak, M. N., Carrier, S., Platt, R. W., Suissa, S., and Azoulay, L., “Phosphodiesterase Type 5 Inhibitors and the Risk of Melanoma Skin Cancer”, Eur Urol, vol. 70, pp. 808-815, 2016.
M. Tuccori, Filion, K. B., Yin, H., Yu, O. H., Platt, R. W., and Azoulay, L., “Pioglitazone use and risk of bladder cancer: population based cohort study”, Bmj, vol. 352, p. i1541, 2016.
R. W. Platt, Delaney, J. A., and Suissa, S., “The positivity assumption and marginal structural models: the example of warfarin use and risk of bleeding”, Eur J Epidemiol, vol. 27, pp. 77-83, 2012.
C. A. Gravel, Filion, K. B., Reynier, P. M., and Platt, R. W., “Postmyocardial Infarction Statin Exposure and the Risk of Stroke with Weighting for Outcome Misclassification”, Epidemiology, vol. 31, pp. 880-888, 2020.
C. E. Lefebvre, Filion, K. B., Reynier, P., Platt, R. W., and Zappitelli, M., “Primary Care Prescriptions of Potentially Nephrotoxic Medications in Children with CKD”, Clin J Am Soc Nephrol, 2019.
V. C. Brunetti, Reynier, P., Azoulay, L., Yu, O. H. Y., Ernst, P., Platt, R. W., and Filion, K. B., “SGLT-2 inhibitors and the risk of hospitalization for community-acquired pneumonia: A population-based cohort study”, Pharmacoepidemiol Drug Saf, 2021.
M. Pang, Schuster, T., Filion, K. B., Eberg, M., and Platt, R. W., “Targeted Maximum Likelihood Estimation for Pharmacoepidemiologic Research”, Epidemiology, vol. 27, pp. 570-7, 2016.
S. M. Grandi, Reynier, P., Platt, R. W., Basso, O., and Filion, K. B., “The timing of onset of hypertensive disorders in pregnancy and the risk of incident hypertension and cardiovascular disease”, Int J Cardiol, vol. 270, pp. 273-275, 2018.
H. T. Ayele, Reynier, P., Azoulay, L., Platt, R. W., Cabaussel, J., Benayoun, S., and Filion, K. B., “Trends in the pharmacological treatment of benign prostatic hyperplasia in the UK from 1998 to 2016: a population-based cohort study”, World J Urol, 2020.
[Page last reviewed 6 April 2021]